🔎 Trials Near Me

Home › Type 1 Diabetes › Florida

Pag-aaral pangklinika para sa Type 1 Diabetes sa Florida

30 pag-aaral para sa Type 1 Diabetes ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

  • Clinical Pharmacology of Miami, Miami
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07803744

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  • Tallahassee Memorial HealthCare, Tallahassee
Nagre-recruitPhase 3
Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07222332

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  • Tallahassee Memorial HealthCare, Tallahassee
Nagre-recruitPhase 3
Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07222137

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • University of Florida College of Medicine- Site Number : 8400054, Gainesville
  • Encore Medical Research - Hollywood- Site Number : 8400061, Hollywood
  • Nemours Children's Speciality Care- Jacksonville- Site Number : 8400040, Jacksonville
  • at 2 pa
Nagre-recruitPhase 3
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Southwest General Healthcare Center, Fort Myers
  • University of Florida, Gainesville
  • Evolution Research Center, Hialeah
  • at 4 pa
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  • University of Florida, Gainesville
Nagre-recruitPhase 2
Edad 4 hanggang 34 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • University of Florida, Gainesville
  • University of Miami, Miami
  • USF Diabetes Center, Tampa
Nagre-recruitPhase 2
Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • University of Florida, Gainesville
  • University of Miami, Miami
Nagre-recruitPhase 1/2
Edad 9 hanggang 20 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07061574

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  • UHealth Diabetes Research Institute, Miami
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04786262

Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families

  • Nemours Children's Health, Jacksonville
Nagre-recruit
Edad 8 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT05268250

HLA Demographics Study in Adults With Type 1 Diabetes

  • University of Florida- Gainesville, Gainesville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06860516

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • University of Florida College of Medicine, Gainesville
  • University of Miami - Gables One Tower, Miami
Nagre-recruitPhase 2
Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07187531

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  • University of Florida, Gainsville
Nagre-recruitPhase 2
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07224321

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

  • AdventHealth Translational Research Institute, Orlando
Nagre-recruitPhase 2
Edad 18 hanggang 40 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05478707

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  • University of Florida - Gainesville, Gainesville
  • University of Miami, Diabetes Research Institute, Miami
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06919354

Adapting Single Sessions Interventions for Type 1 Diabetes

  • Nemours Children's Hospital - FL, Orlando
Nagre-recruit
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06752369

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

  • Nemours Children's Health, Jacksonville
  • Nemours Children's Health, Orlando
Nagre-recruitObservasyonal na pag-aaral
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT05849753

Transdisciplinary Care for Young Adults With Type 1 Diabetes

  • Nemours Children's Health, Florida, Orlando
Nagre-recruit
Edad 17 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06172166

Registry for Stage 2 Type 1 Diabetes

  • University of Florida Health- Site Number : 8400035, Gainesville
  • Nemours Children's Speciality Care- Jacksonville- Site Number : 8400006, Jacksonville
  • University of Miami Miller School of Medicine- Site Number : 8400037, Miami
  • at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06481904

Immune Function and the Progression to T1D

  • Kieran McGrail, Gainesville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 0 hanggang 100 · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT05899439

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • AdventHealth, Orlando
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT06217302

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • Diabetes Research Institute, Miami
Nagre-recruit
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01999361

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

  • Diabetes Research Institute, Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT02000687

Long Term Follow up of Recipients of Functional Islet Allografts

  • Diabetes Research Institute, Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01999374

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

  • Bascom Palmer Eye Institute, Miami
  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT02846571

Closed Loop and Education for Hypoglycemia Awareness Restoration

  • AdventHealth, Orlando
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 3, 2026 · NCT06325202

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
Nagre-recruitPhase 1/2
Edad 18 hanggang 35 · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT05626712

Twiist Postmarket Surveillance Study for Type 1 Diabetes

  • Jaeb Center for Health Research, Tampa
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07356089

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

  • University of Florida, Gainesville
Nagre-recruitPhase 2
Edad 6 hanggang 35 · Lahat ng kasarian · Na-update Nob 26, 2025 · NCT06455319

TrialNet Pathway to Prevention of T1D

  • University of Florida, Gainesville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 45 · Lahat ng kasarian · Na-update Hul 1, 2025 · NCT00097292

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.